TPI-1917-49

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTPI-1917-49
Drug Alias Namebeta amyloid antagonists (Torrey Pines Institute for Molecular Studies)TPI-1917-49
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTorrey Pines Institute For Molecular Studies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTorrey Pines Institute For Molecular Studies
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A